血液造血干细胞移植用于原发性免疫缺陷
Nouf Alsaati1, Alexandra Grier1, Elisa Ochfeld1
1From the Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia Pennsylvania; and.
造血干细胞移植 (HSCT) 为原发性免疫缺陷 (免疫的先天性错误) 提供了最终的治疗方法. 本综述指导过敏学家-免疫学家对HSCT基础知识,结果和终身患者监测.
科学领域:
- 临床免疫学临床免疫学
- 移植医学 移植医学
- 血液学 血液学 血液学
背景情况:
- 初级免疫缺陷或先天性免疫错误 (IEI) 源于源自血液造血干细胞的血细胞缺陷.
- 血造干细胞移植 (HSCT) 已经是五十年来IEI的终极治疗方法.
- 免疫学和移植医学的进步使IEI的更好的诊断和成功的HSCT成为可能.
研究的目的:
- 为管理接受HSCT的IEI患者的过敏学家-免疫学家提供实际指导.
- 涵盖HSCT基础知识,特定IEI类型的结果和移植前护理.
- 强调终身的HSCT后免疫学和医疗监测.
主要方法:
- 对IEI和HSCT当前文献和临床实践的审查.
- 综合有关诊断进展和治疗结果的信息.
- 为HSCT前后的管理制定指南.
主要成果:
- 越来越多地确定IEI的单一原因.
- 提高了成功率和HSCT在IEI治疗中的更广泛应用.
- 承认对综合性HSCT前后护理的急需.
结论:
- 过敏学家-免疫学家在诊断和管理IEI患者在HSCT前后发挥关键作用.
- 成功的HSCT需要精心的移植前支持和长期监测.
- 本综述提供了通过HSCT优化IEI患者护理的基本指导.
更多相关视频
11:16Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
Published on: February 15, 2019
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
相关概念视频
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Regulation of Hematopoietic Stem Cells
iPS Cell Differentiation
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
